Constellation Brands, an international producer and marketer of beer, wine and spirits (including Corona beer, which has temporarily suspended production in Mexico because of the coronavirus pandemic), has appointed Mike McGrew to the newly created role of executive vice president, chief communications and corporate social responsibility officer. McGrew joined the company in 2014, most recently serving as senior vice president, corporate communications. He has also served on Constellation’s operational executive management committee. Before coming to Constellation Brands, McGrew was senior director, communications for the Americas at industrial supply company W.W. Grainger. In his new post, he will be responsible for overseeing all aspects of Constellation’s communications efforts, including internal and external global communications, brand public relations, corporate branding and reputation, investor relations, and corporate social responsibility.
eGenesis, a biotechnology company that leverages gene editing technologies to develop human-compatible organs to address the global organ shortage, has appointed David Carmel senior vice president, public affairs and communications. Prior to joining eGenesis, Carmel served as vice president of medical affairs and strategic alliances at Atara Biotherapeutics. He was previously co-founder and principal of Carmel Asset Management, where he was responsible for life science investments. In addition to having held positions in public affairs and business development for StemCyte, Pfizer, and Johnson & Johnson, Carmel served as the White House Fellow for the Secretary of the Treasury from 2002 to 2003 was appointed by Governor Andrew Cuomo to the New York Life Science Advisory Board. In his new post, he will lead eGenesis’ external outreach efforts to advocacy organizations, professional societies, policymakers, and investors.
Veracyte, a leading genomic diagnostics company, has named Tracy Morris vice president of corporate communications and investor relations, effective immediately. Morris has served as a communications consultant to Veracyte for nearly ten years, providing communications leadership and support for the company’s market introduction, IPO, acquisition and collaboration announcements, product and clinical milestones and ongoing investor relations activities. Earlier in her career, she was director of U.S. marketing communications for Digene Corporation. In her new role, Morris will be responsible for developing and executing Veracyte’s communications strategy to shareholders, customers, patients, employees and other audiences.